A team from University Hospitals Seidman Cancer Center is launching the nation’s first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, Lipofen) as an investigational and potential treatment for patients with HPV+ cervical and HPV+ head and neck cancer (HNSCC).
Radiology AI Marketplace CARPL Secures $6M to Bridge Radiologist Gap with Seamless Integration Tools
Dr. Vidur Mahajan, Founder/CEO at CARPL What You Should Know: – As healthcare demands rise with an aging population and growing emphasis on early disease
February 2, 2024